References
R Bergner K Dill D Boerner M Uppenkamp (2002) ArticleTitleElimination of intravenously administered ibandronate in patients on haemodialysis: a monocentre open study. Nephrol Dial Transplant 17 1281–1285
D Lee K Kurokawa (1991) Phosphorous metabolism physiology M Maxwell C Kleeman R Narins (Eds) Clinical disorders of fluid and electrolyte metabolism Panamericana Buenos Aires 224–228
F Llach (1996) Renal osteodystrophy C Jacobs C Kjellstrand K Koch J Winchester (Eds) Replacement of Renal Function by Diálisis Kluwer Academic Publisher Dordrecht 1203
Fernandez E. Cardiovascular role of phosphorous. www./uninet./edu/cin2003/conf/fernandez/fernandez.htlm.
J Delmez M Kaye (2001) Bone disease J Daugirdas P Blake T Ing (Eds) Handbook of dialysis Lippincott Williams & Williams Philadelphia 530–545
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Musso, C., Guelman, R., Varela, F. et al. Ibandronate improves hyperphosphatemia in dialysis patients with hyperparathyroidism. Int Urol Nephrol 36, 625–627 (2004). https://doi.org/10.1007/s11255-004-2077-5
Issue Date:
DOI: https://doi.org/10.1007/s11255-004-2077-5